Pharmagreen Biotech Inc. (PHBI)
OTCMKTS · Delayed Price · Currency is USD
0.0019
+0.0001 (5.56%)
Oct 27, 2025, 3:50 PM EDT
Pharmagreen Biotech Company Description
Pharmagreen Biotech Inc. operates as a nutraceutical company, engages in the formulating products from blends of therapeutic plants and fungi in North America.
The company’s primary product is MaxGenomic supplement, a proprietary blend and formulated medicinal mushrooms and medical plants to support the human mind and body.
It also provides consulting services for plant genetic selection, tissue culture technologies for starter plantlets production, SOPs for cultivation and live storage of any plant species services.
It sells its products through online stores, such as Amazon and Shopify. Pharmagreen Biotech Inc. is headquartered in Coquitlam, Canada.
Pharmagreen Biotech Inc.
| Country | United States |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| CEO | Peter Wojcik |
Contact Details
Address: 2987 Blackbear Court Coquitlam, Nevada V3E 3A2 Canada | |
| Phone | 702 803 9404 |
| Website | pharmagreen.ca |
Stock Details
| Ticker Symbol | PHBI |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | October - September |
| Reporting Currency | USD |
| ISIN Number | US71716C1099 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Peter Wojcik B.A. | President, Chief Executive Officer, Secretary, Treasurer and Director |
| Terry Kwan B.Com., C.A., CPA | Chief Financial Officer and Principal Accounting Officer |